Effective multi-strain inhibition of influenza virus by anionic gold nanoparticles

MedChemComm

Volumn 2, Issue 5, 2011, Pages 421-423

  Sametband, Matias ^a   Shukla, Sourabh ^a   Meningher, Tal ^a,b   Hirsh, Shira ^a,b   Mendelson, Ella ^b   Sarid, Ronit ^a   Gedanken, Aharon ^a   Mandelboim, Michal ^b  

^a BAR ILAN UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOPARTICLE; MESNA; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; IN VITRO STUDY; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURFACE CHARGE; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS INHIBITION;

ORTHOMYXOVIRIDAE;

EID: 79959550699     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c0md00229a     Document Type: Article

References (19)

1. http://www.who.int/csr/don/2010-02-19/en/index.html.
2. W. Fiers, M. De Filett., A. Birkett, S. Neirynck and W. Min Jou, Virus Res., 2004, 103, 173-176.
3. M. von Itzstein, Nat. Rev. Drug Discovery, 2007, 6, 967-974.
4. E. De Clercq and J. Neyts, Trends Pharmacol. Sci., 2007, 28, 280-285.
5. G. A. Poland, R. M. Jacobson and I. G. Ovsyannikova, Clin. Infect. Dis., 2009, 48, 1254-1256.
6. J. J. Skehel and D. C. Wiley, Annu. Rev. Biochem., 2000, 69, 531-569.
7. (a) M. Hosoya, J. Balzarini, S. Shigeta and E. De Clercq, Antimicrob. Agents Ch., 1991, 35, 2515-2520;
8. (b) S. Ikeda, J. Neyts, S. Verma, A. Wickramasinghe, P. Mohan and E. De Clercq, Antimicrob. Agents Ch., 1994, 38, 256-259;
9. (c) M. Lü-Mattli, Arch. Virol., 2000, 145, 2233-2248.
10. D. L. Bodian, R. B. Yamasaki, R. L. Buswell, J. F. Stearns, J. M. White and I. D. Kuntz, Biochemistry, 1993, 32, 2967-2978.
11. A. Verma and F. Stellacci, Small, 2010, 6, 12-21.
12. (a) C. A. Simpson, B. J. Huffman, A. E. Gerdon and D. E. Cliffel, Chem. Res. Toxicol., 2010, 23, 1608-1616;
13. (b) Y. S. Chen, Y. C. Hung, I. Liau and G. S. Huang, Nanoscale Res. Lett., 2009, 4, 858-864;
14. (c) N. Lewinski, V. Colvin and R. Drezek, Small, 2008, 4, 26-49.
15. D. Baram-Pinto, S. Shukla, A. Gedanken and R. Sarid, Small, 2010, 6, 1044-1050.
16. P. D. Gianvincenzo, M. Marradi, O. M. Martinez-Ávila, L. M. Bedoya, J. Alcami and S. Penades, Bioorg. Med. Chem. Lett., 2010, 20, 2718-2721.
17. M. E. Aubin-Tamand K. Hamad-Schifferli, Langmuir, 2005, 21, 12080-12084.
18. P. Schoen, J. Cower, D. K. F. Meijer, J. Wilschut and P.-J. Swart, Biochem. Pharmacol., 1997, 53, 995-1003.
19. D. Baram-Pinto, S. Shukla, N. Perkas, A. Gedanken and R. Sarid, Bioconjugate Chem., 2009, 20, 1497-1502.